Miromatrix Medical Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2022	2021	2020	2019
Market Capitalization	93	63	95	-	-
Market Cap Growth	-	-34.20%	-	-	-
Enterprise Value	79	40	42	3	-2
PE Ratio	-1.30	-2.09	-6.47	-	-
PS Ratio	97.02	65.55	2872.87	-	-
PB Ratio	5.98	2.39	1.76	-	-
P/FCF Ratio	-1.46	-2.25	-5.22	-	-
P/OCF Ratio	-1.47	-2.34	-6.41	-	-
EV/Sales Ratio	82.79	42.01	1276.64	62.28	-8.45
EV/EBITDA Ratio	-0.84	-1.39	-3.04	-0.31	0.58
EV/EBIT Ratio	-0.81	-1.34	-3.00	-0.30	0.53
EV/FCF Ratio	-0.90	-1.44	-2.32	-0.36	0.25
Debt / Equity Ratio	0.21	0.14	0.02	-0.14	-0.03
Debt / EBITDA Ratio	-0.12	-0.12	-0.06	-0.77	-0.31
Debt / FCF Ratio	-0.13	-0.13	-0.05	-0.90	-0.14
Quick Ratio	3.40	5.44	12.03	0.56	2.33
Current Ratio	3.46	5.52	12.12	0.57	2.39
Asset Turnover	0.03	0.02	0.00	0.01	-
Interest Coverage	-589.56	-626.67	-22.90	-14.70	-82.64
Return on Equity (ROE)	-120.50%	-81.90%	-46.80%	22.30%	-
Return on Assets (ROA)	-90.70%	-67.70%	-29.70%	-158.60%	-
Return on Capital (ROIC)	-152.42%	-102.38%	-30.87%	23.48%	22.31%
Earnings Yield	-29.49%	-47.93%	-15.44%	-	-
FCF Yield	-26.41%	-44.39%	-19.15%	-	-
Buyback Yield / Dilution	-30.72%	-80.48%	-430.44%	-5.96%	-
Total Shareholder Return	-30.72%	-80.48%	-430.44%	-5.96%	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).